In the case of YAP1-activated cells, MAPK and PI3K were not activated in pancreatic cancer models resistant to Kras depletion, while these pathways were hyperactive in colon and lung cancer models, suggesting lineage-specific rewiring of these pathways. This evidence concerns the gene KRAS and pancreatic neoplasm.